skip to main content
Show Results with:

Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension

Narine, L. et al.

Current medical research and opinion. VOL 21; NUMB 12, ; 2005, 2007-2016 -- LIBRA PHARM LTD (pages 2007-2016) -- 2005

Online access

Searching Remote Databases, Please Wait